These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38830506)

  • 1. Implications of chronic moderate protein-deficiency malnutrition on doxorubicin pharmacokinetics and cardiotoxicity in early post-weaning stage.
    Garg M; Gandhi K; Gera P; Jadhav SM; Mohanty B; Gurjar M; Sandupatla B; Gala R; Chaudhari P; Prasad M; Chinnaswamy G; Gota V
    Life Sci; 2024 Aug; 350():122765. PubMed ID: 38830506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of low-protein diet on anthracycline pharmacokinetics and cardiotoxicity.
    El-Demerdash E; Ali AA; El-Taher DE; Hamada FM
    J Pharm Pharmacol; 2012 Mar; 64(3):344-52. PubMed ID: 22309266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for
    Chakouri N; Farah C; Matecki S; Amedro P; Vincenti M; Saumet L; Vergely L; Sirvent N; Lacampagne A; Cazorla O
    Theranostics; 2020; 10(18):8130-8142. PubMed ID: 32724462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Polymorphisms Affecting Cardiac Biomarker Concentrations in Children with Cancer: an Analysis from the "European Paediatric Oncology Off-patents Medicines Consortium" (EPOC) Trial.
    Hellmann F; Völler S; Krischke M; Jamieson D; André N; Bisogno G; Boddy A; Hempel G
    Eur J Drug Metab Pharmacokinet; 2020 Jun; 45(3):413-422. PubMed ID: 31981210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multiscale Physiologically-Based Pharmacokinetic Model for Doxorubicin to Explore its Mechanisms of Cytotoxicity and Cardiotoxicity in Human Physiological Contexts.
    He H; Liu C; Wu Y; Zhang X; Fan J; Cao Y
    Pharm Res; 2018 Jul; 35(9):174. PubMed ID: 29987398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-weaning protein malnutrition in the rat produces short and long term metabolic impairment, in contrast to earlier and later periods.
    Miñana-Solis Mdel C; Escobar C
    Int J Biol Sci; 2008; 4(6):422-32. PubMed ID: 19043606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomal co-delivered oleanolic acid attenuates doxorubicin-induced multi-organ toxicity in hepatocellular carcinoma.
    Sarfraz M; Afzal A; Raza SM; Bashir S; Madni A; Khan MW; Ma X; Xiang G
    Oncotarget; 2017 Jul; 8(29):47136-47153. PubMed ID: 28525367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiscale and Translational Quantitative Systems Toxicology, Pharmacokinetic-Toxicodynamic Modeling Analysis for Assessment of Doxorubicin-Induced Cardiotoxicity.
    Vaidya TR; Mody H; Franco YL; Brown A; Ait-Oudhia S
    AAPS J; 2021 Jan; 23(1):18. PubMed ID: 33404976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GATA4-targeted compound exhibits cardioprotective actions against doxorubicin-induced toxicity in vitro and in vivo: establishment of a chronic cardiotoxicity model using human iPSC-derived cardiomyocytes.
    Karhu ST; Kinnunen SM; Tölli M; Välimäki MJ; Szabó Z; Talman V; Ruskoaho H
    Arch Toxicol; 2020 Jun; 94(6):2113-2130. PubMed ID: 32185414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of protection of moderately diet restricted rats against doxorubicin-induced acute cardiotoxicity.
    Mitra MS; Donthamsetty S; White B; Latendresse JR; Mehendale HM
    Toxicol Appl Pharmacol; 2007 Nov; 225(1):90-101. PubMed ID: 17904602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A short-time model to study relevant indices of cardiotoxicity of doxorubicin in the rat.
    Hole LD; Larsen TH; Fossan KO; Limé F; Schjøtt J
    Toxicol Mech Methods; 2013 Jul; 23(6):412-8. PubMed ID: 23379389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doxorubicin-Induced Cardiotoxicity in Collaborative Cross (CC) Mice Recapitulates Individual Cardiotoxicity in Humans.
    Zeiss CJ; Gatti DM; Toro-Salazar O; Davis C; Lutz CM; Spinale F; Stearns T; Furtado MB; Churchill GA
    G3 (Bethesda); 2019 Aug; 9(8):2637-2646. PubMed ID: 31263061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetic modelling of doxorubicin and doxorubicinol in children with cancer: is there a relationship with cardiac troponin profiles?
    Kunarajah K; Hennig S; Norris RLG; Lobb M; Charles BG; Pinkerton R; Moore AS
    Cancer Chemother Pharmacol; 2017 Jul; 80(1):15-25. PubMed ID: 28444427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of tamoxifen pretreatment on the pharmacokinetics, metabolism and cardiotoxicity of doxorubicin in female rats.
    Vaidyanathan S; Boroujerdi M
    Cancer Chemother Pharmacol; 2000; 46(3):185-92. PubMed ID: 11021735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrionopathy phenotype in doxorubicin-treated Wistar rats depends on treatment protocol and is cardiac-specific.
    Pereira GC; Pereira SP; Pereira CV; Lumini JA; Magalhães J; Ascensão A; Santos MS; Moreno AJ; Oliveira PJ
    PLoS One; 2012; 7(6):e38867. PubMed ID: 22745682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aptamer-drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity.
    Dou XQ; Wang H; Zhang J; Wang F; Xu GL; Xu CC; Xu HH; Xiang SS; Fu J; Song HF
    Int J Nanomedicine; 2018; 13():763-776. PubMed ID: 29440899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scutellarin protects against doxorubicin-induced acute cardiotoxicity and regulates its accumulation in the heart.
    Sun XP; Wan LL; Yang QJ; Huo Y; Han YL; Guo C
    Arch Pharm Res; 2017 Jul; 40(7):875-883. PubMed ID: 28315259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Moderate Malnutrition on the Pharmacokinetics of Etoposide and Vincristine in Freshly Weaned Rats.
    Garg M; Gandhi K; Jadhav SM; Gurjar M; Gota V
    Eur J Drug Metab Pharmacokinet; 2023 Nov; 48(6):657-663. PubMed ID: 37700116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-like receptor 5 deficiency diminishes doxorubicin-induced acute cardiotoxicity in mice.
    Ma ZG; Kong CY; Wu HM; Song P; Zhang X; Yuan YP; Deng W; Tang QZ
    Theranostics; 2020; 10(24):11013-11025. PubMed ID: 33042267
    [No Abstract]   [Full Text] [Related]  

  • 20. Levosimendan prevents doxorubicin-induced cardiotoxicity in time- and dose-dependent manner: implications for inotropy.
    Efentakis P; Varela A; Chavdoula E; Sigala F; Sanoudou D; Tenta R; Gioti K; Kostomitsopoulos N; Papapetropoulos A; Tasouli A; Farmakis D; Davos CH; Klinakis A; Suter T; Cokkinos DV; Iliodromitis EK; Wenzel P; Andreadou I
    Cardiovasc Res; 2020 Mar; 116(3):576-591. PubMed ID: 31228183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.